Melissa Ramirez
Child & Adolescent Psychiatry · Phoenix, AZNPI 1750610184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 565 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 565 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Corium, LLC$885
- Otsuka America Pharmaceutical, Inc.$877
- Sunovion Pharmaceuticals Inc.$850
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$653
- Johnson & Johnson$649
- plus $4K from 25 others
What the payments were for
- Food & beverage$9,326100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 105 | $1,512 |
| Corium, LLC | 44 | $885 |
| Otsuka America Pharmaceutical, Inc. | 62 | $877 |
| Sunovion Pharmaceuticals Inc. | 43 | $850 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 51 | $653 |
| Johnson & Johnson | 24 | $649 |
| Ironshore Pharmaceuticals Inc. | 30 | $544 |
| Alkermes, Inc. | 20 | $479 |
| Lundbeck LLC | 16 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $313 |
| Supernus Pharmaceuticals, Inc. | 15 | $311 |
| Vanda Pharmaceuticals Inc. | 18 | $309 |
| Tris Pharma Inc | 17 | $275 |
| Neos Therapeutics, LP | 37 | $249 |
| Neurocrine Biosciences, Inc. | 6 | $187 |
| Teva Pharmaceuticals USA, Inc. | 7 | $140 |
| Vertical Pharmaceuticals, LLC | 5 | $129 |
| Bausch Health US, LLC | 6 | $102 |
| Almatica Pharma LLC | 5 | $97 |
| Adlon Therapeutics L.p. | 6 | $96 |
| Axsome Therapeutics, Inc. | 6 | $94 |
| Shire North American Group Inc | 3 | $41 |
| Harmony Biosciences LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Merck | 2 | $35 |
| Noven Therapeutics, LLC | 2 | $29 |
| Eisai Inc. | 2 | $25 |
| Portola Pharmaceuticals, LLC | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Neuronetics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,356 in reported general payments places this provider in the 90th percentile of 80 child & adolescent psychiatry providers in Arizona.
See all child & adolescent psychiatry providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 12 | $210 |
| Aripiprazole | 11 | $202 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Phoenix
- Suzanne DonPhoenix$119K
- Nancy BucknerPhoenix$1K
- Bruce HolzmanPhoenix$1K
- Shalini TharaniPhoenix$1K
- Raymond BunchPhoenix$1K
- Priti PatelPhoenix$990
- Urszula KotlowPhoenix$934
- Chiranjir NarinePhoenix$783
- Houshang AminianPhoenix$520
- Lydia CohanPhoenix$516
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.